Role of glucocorticoid-induced leucine zipper (GILZ) in bone acquisition

Journal of Biological Chemistry

Volumn 289, Issue 28, 2014, Pages 19373-19382

  Pan, Guodong ^a,b   Cao, Jay ^c   Yang, Nianlan ^a   Ding, Kehong ^a   Fan, Cheng ^a   Xiong, Wen Cheng ^a   Hamrick, Mark ^a   Isales, Carlos M ^a   Shi, Xing Ming ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b WUHAN UNIVERSITY   (China)

^c GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; GENES; HORMONES; MAMMALS; MERGERS AND ACQUISITIONS; RAT CONTROL; TISSUE; TRANSCRIPTION; TRANSCRIPTION FACTORS;

ADIPOGENIC DIFFERENTIATIONS; ANTI-INFLAMMATORY EFFECTS; BONE FORMATION RATES; BONE MARROW STROMAL CELLS; GENE TRANSCRIPTIONS; GLUCOCORTICOID-INDUCED LEUCINE ZIPPERS; OSTEOGENIC DIFFERENTIATION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR;

BONE;

CCAAT ENHANCER BINDING PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID INDUCED LEUCINE ZIPPER; LEUCINE ZIPPER PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CULTURE; BONE MASS; CONTROLLED STUDY; DNA PROTEIN COMPLEX; FEMALE; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROGENITOR CELL LINE; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; STROMA CELL; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ARTHRITIS; GLUCOCORTICOID; INFLAMMATION; OSTEOBLAST; OSTEOPOROSIS;

ANIMALS; BONE MARROW CELLS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION; MALE; MICE; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOGENESIS; PPAR GAMMA; PROMOTER REGIONS, GENETIC; RATS; STEM CELLS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84904161403     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.535237     Document Type: Article

References (38)

1. Nishimura, J., and Ikuyama, S. (2000) Glucocorticoid-induced osteoporosis: pathogenesis and management. J. Bone Miner. Metab. 18, 350-352
2. Clowes, J. A., Peel, N., and Eastell, R. (2001) Glucocorticoid-induced osteoporosis. Curr. Opin. Rheumatol. 13, 326-332 (Pubitemid 32831827)
3. Soule, S. (1999) Addison's disease in Africa: a teaching hospital experience. Clin. Endocrinol. (Oxf.) 50, 115-120
4. Valero, M. A., Leon, M., Ruiz Valdepeñas, M. P., Larrodera, L., Lopez, M. B., Papapietro, K., Jara, A., and Hawkins, F. (1994) Bone density and turnover in Addison's disease: effect of glucocorticoid treatment. Bone Miner. 26, 9-17
5. Sher, L. B., Woitge, H. W., Adams, D. J., Gronowicz, G. A., Krozowski, Z., Harrison, J. R., and Kream, B. E. (2004) Transgenic expression of 11β-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone. Endocrinology 145, 922-929 (Pubitemid 38183836)
6. Sher, L. B., Harrison, J. R., Adams, D. J., and Kream, B. E. (2006) Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling. Calcif. Tissue Int 79, 118-125 (Pubitemid 44306169)
7. Yang, M., Trettel, L. B., Adams, D. J., Harrison, J. R., Canalis, E., and Kream, B. E. (2010) Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation. Bone 47, 573-582
8. Rauch, A., Seitz, S., Baschant, U., Schilling, A. F., Illing, A., Stride, B., Kirilov, M., Mandic, V., Takacz, A., Schmidt-Ullrich, R., Ostermay, S., Schinke, T., Spanbroek, R., Zaiss, M. M., Angel, P. E., Lerner, U. H., David, J. P., Reichardt, H. M., Amling, M., Schütz, G., and Tuckermann, J. P. (2010) Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab. 11, 517-531
9. D'Adamio, F., Zollo, O., Moraca, R., Ayroldi, E., Bruscoli, S., Bartoli, A., Cannarile, L., Migliorati, G., and Riccardi, C. (1997) A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity. 7, 803-812 (Pubitemid 28064893)
10. Cannarile, L., Zollo, O., D'Adamio, F., Ayroldi, E., Marchetti, C., Tabilio, A., Bruscoli, S., and Riccardi, C. (2001) Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene. Cell Death Differ. 8, 201-203 (Pubitemid 32201367)
11. Ayroldi, E., Migliorati, G., Bruscoli, S., Marchetti, C., Zollo, O., Cannarile, L., D'Adamio, F., and Riccardi, C. (2001) Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor κB. Blood 98, 743-753
12. Mittelstadt, P. R., and Ashwell, J. D. (2001) Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J. Biol. Chem. 276, 29603-29610
13. Yang, N., Zhang, W., and Shi, X. M. (2008) Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression. J. Cell Biochem. 103, 1760-1771 (Pubitemid 351501908)
14. Zhang, W., Yang, N., and Shi, X. M. (2008) Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ). J. Biol. Chem. 283, 4723-4729
15. He, L., Yang, N., Isales, C. M., and Shi, X. M. (2012) Glucocorticoid-induced leucine zipper (GILZ) antagonizes TNF-α inhibition of mesenchymal stem cell osteogenic differentiation. PLoS One 7, e31717
16. Shi, X., Shi, W., Li, Q., Song, B., Wan, M., Bai, S., and Cao, X. (2003) A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep. 4, 374-380 (Pubitemid 36622002)
17. Woitge, H., Harrison, J., Ivkosic, A., Krozowski, Z., and Kream, B. (2001) Cloning and in vitro characterization of α1(I)-collagen 11β-hydroxysteroid dehydrogenase type 2 transgenes as models for osteoblast-selective inactivation of natural glucocorticoids. Endocrinology 142, 1341-1348 (Pubitemid 32202847)
18. Cao, J. J., Gregoire, B. R., and Gao, H. (2009) High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice. Bone 44, 1097-1104
19. Xia, W.-F., Jung, J.-U., Shun, C., Xiong, S., Xiong, L., Shi, X.-M., Mei, L., and Xiong, W.-C. (2013) Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine. J. Bone Miner. Res. 28, 2122-2135
20. Pfaffl, M. W., Horgan, G. W., and Dempfle, L. (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36
21. Rutter, M. M., Markoff, E., Clayton, L., Akeno, N., Zhao, G., Clemens, T. L., and Chernausek, S. D. (2005) Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5. Bone 36, 224-231 (Pubitemid 40283579)
22. Zhang, W., Ou, G., Hamrick, M., Hill, W., Borke, J., Wenger, K., Chutkan, N., Yu, J., Mi, Q. S., Isales, C. M., and Shi, X. M. (2008) Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells. J. Bone Miner. Res. 23, 1118-1128 (Pubitemid 351915734)
23. Shi, X. M., Blair, H. C., Yang, X., McDonald, J. M., and Cao, X. (2000) Tandem repeat of C/EBP binding sites mediates PPARγ2 gene transcription in glucocorticoid-induced adipocyte differentiation. J. Cell Biochem. 76, 518-527 (Pubitemid 30078460)
24. Shi, X., Bai, S., Li, L., and Cao, X. (2001) Hoxa-9 represses transforming growth factor-β-induced osteopontin gene transcription. J. Biol. Chem. 276, 850-855 (Pubitemid 32050387)
25. Clarke, S. L., Robinson, C. E., and Gimble, J. M. (1997) CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor γ2 promoter. Biochem. Biophys. Res. Commun. 240, 99-103 (Pubitemid 27503755)
26. Elberg, G., Gimble, J. M., and Tsai, S. Y. (2000) Modulation of the murine peroxisome proliferator-activated receptor γ2 promoter activity by CCAAT/enhancer-binding proteins. J. Biol. Chem. 275, 27815-27822
27. Hamm, J. K., Park, B. H., and Farmer, S. R. (2001) A role for C/EBPβ in regulating peroxisome proliferator-activated receptor γ activity during adipogenesis in 3T3-L1 preadipocytes. J. Biol. Chem. 276, 18464-18471
28. Gimble, J. M., Ptitsyn, A. A., Goh, B. C., Hebert, T., Yu, G., Wu, X., Zvonic, S., Shi, X. M., and Floyd, Z. E. (2009) Delta sleep-inducing peptide and glucocorticoid-induced leucine zipper: potential links between circadian mechanisms and obesity? Obes. Rev. 10, 46-51
29. Yao, W., Cheng, Z., Busse, C., Pham, A., Nakamura, M. C., and Lane, N. E. (2008) Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid- treated mice. Arthritis Rheum. 58, 1674-1686 (Pubitemid 351847520)
30. Morrison, N., and Eisman, J. (1993) Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter. J. Bone Miner. Res. 8, 969-975 (Pubitemid 23219386)
31. Kassel, O., Sancono, A., Krätzschmar, J., Kreft, B., Stassen, M., and Cato, A. C. (2001) Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20, 7108-7116 (Pubitemid 34062302)
32. Jaiswal, R. K., Jaiswal, N., Bruder, S. P., Mbalaviele, G., Marshak, D. R., and Pittenger, M. F. (2000) Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J. Biol. Chem. 275, 9645-9652 (Pubitemid 30185197)
33. Park, O. J., Kim, H. J., Woo, K. M., Baek, J. H., and Ryoo, H. M. (2010) FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization. J. Biol. Chem. 285, 3568-3574
34. Song, C. Z., Tian, X., and Gelehrter, T. D. (1999) Glucocorticoid receptor inhibits transforming growth factor-β signaling by directly targeting the transcriptional activation function of Smad3. Proc. Natl. Acad. Sci. U.S.A. 96, 11776-11781 (Pubitemid 29502808)
35. Kassem, M., Kveiborg, M., and Eriksen, E. F. (2000) Production and action of transforming growth factor-β in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol. Eur. J. Clin. Invest. 30, 429-437 (Pubitemid 30251400)
36. Tang, Y., Wu, X., Lei, W., Pang, L., Wan, C., Shi, Z., Zhao, L., Nagy, T. R., Peng, X., Hu, J., Feng, X., Van Hul, W., Wan, M., and Cao, X. (2009) TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med. 15, 757-765
37. Ayroldi, E., and Riccardi, C. (2009) Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 23, 3649-3658
38. Beaulieu, E., Ngo, D., Santos, L., Yang, Y. H., Smith, M., Jorgensen, C., Escriou, V., Scherman, D., Courties, G., Apparailly, F., and Morand, E. F. (2010) Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis. Arthritis Rheum. 62, 2651-2661